trazimera poudre pour solution
pfizer canada ulc - trastuzumab - poudre pour solution - 150mg - trastuzumab 150mg - antineoplastic agents
emgality solution
eli lilly canada inc - galcanÉzumab - solution - 120mg - galcanÉzumab 120mg - calcitonin-gene-related peptide (cgrp) antagonists
emgality solution
eli lilly canada inc - galcanÉzumab - solution - 120mg - galcanÉzumab 120mg - calcitonin-gene-related peptide (cgrp) antagonists
ultomiris solution
alexion pharma gmbh - ravulizumab - solution - 10mg - ravulizumab 10mg - immunosuppressive agents
tecentriq solution
hoffmann-la roche limited - atÉzolizumab - solution - 840mg - atÉzolizumab 840mg - antineoplastic agents
nucala solution
glaxosmithkline inc - mépolizumab - solution - 100mg - mépolizumab 100mg - immunosuppressive agents
nucala solution
glaxosmithkline inc - mépolizumab - solution - 100mg - mépolizumab 100mg - immunosuppressive agents
fasenra pen solution
astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists
kanjinti trousse
amgen canada inc - trastuzumab - trousse - 420mg - trastuzumab 420mg - antineoplastic agents
emgality solution
eli lilly canada inc - galcanÉzumab - solution - 100mg - galcanÉzumab 100mg - calcitonin-gene-related peptide (cgrp) antagonists